Skip to main content

Mike the Pike Productions, Inc. Provides Details on Shareholder Dividends

Mike the Pike Productions, Inc. (MTP) (OTC: MIKP) (www.mtpprods.com) announced details on the dividend program for shareholders today. Dividends will be instituted on a quarterly basis based on return on investment (ROI) that the film division earns effective immediately. Dividends will be paid in a combination of stock or cash depending on revenues.

The percentage of the dividend has yet to be determined however, MTP has several projects with revenue potential in excess of $60M including sci-fi thriller ‘White Space’ and George R.R. Martin’s The Skin Trade. If these revenues are realized, the dividend could be substantial. To date, MTP’s financing has been arranged and one or more of the company’s productions could make it to the big screen which would provide shareholders with a substantial dividend.

“With the purchase of MIKP, shareholders are with us on a journey that could lead to a valuation with regard to the dividend which is substantially higher than the current value of our stock,” said MTP CEO Mark B. Newbauer. “We also expect to expand the dividend to include quarterly stock dividends once we have achieved revenue numbers and profitability based on the projections of $60M on each of our projects which we have outlined. This is a real possibility because we’d have the financial backing to do so,” said Newbauer.

Check out IPOdesktop’s Mike the Pike Productions Analyst Report

Want more than just press releases? Check out the MTP BLOG.

Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contacts:

The Nuemark Group
Phone: 860-484-3727
www.NuemarkGroup.com
Investors@nuemarkgroup.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.